These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24986335)

  • 1. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.
    Oremus M; Don-Wauchope A; McKelvie R; Santaguida PL; Hill S; Balion C; Booth R; Brown JA; Ali U; Bustamam A; Sohel N; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):471-505. PubMed ID: 24986335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.
    Santaguida PL; Don-Wauchope AC; Oremus M; McKelvie R; Ali U; Hill SA; Balion C; Booth RA; Brown JA; Bustamam A; Sohel N; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):453-70. PubMed ID: 25062653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods.
    Oremus M; McKelvie R; Don-Wauchope A; Santaguida PL; Ali U; Balion C; Hill S; Booth R; Brown JA; Bustamam A; Sohel N; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):413-9. PubMed ID: 24953975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.
    Balion C; Santaguida PL; Hill S; Worster A; McQueen M; Oremus M; McKelvie R; Booker L; Fagbemi J; Reichert S; Raina P
    Evid Rep Technol Assess (Full Rep); 2006 Sep; (142):1-147. PubMed ID: 17764210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.
    Hill SA; Booth RA; Santaguida PL; Don-Wauchope A; Brown JA; Oremus M; Ali U; Bustamam A; Sohel N; McKelvie R; Balion C; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):421-38. PubMed ID: 24957908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review.
    Santaguida PL; Don-Wauchope AC; Ali U; Oremus M; Brown JA; Bustamam A; Hill SA; Booth RA; Sohel N; McKelvie R; Balion C; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):507-19. PubMed ID: 25052418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
    Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
    Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
    Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
    Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
    Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide-guided therapy: a systematic review.
    Balion C; McKelvie R; Don-Wauchope AC; Santaguida PL; Oremus M; Keshavarz H; Hill SA; Booth RA; Ali U; Brown JA; Bustamam A; Sohel N; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):553-64. PubMed ID: 25074674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
    Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
    Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    Myhre PL; Vaduganathan M; Claggett B; Packer M; Desai AS; Rouleau JL; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2019 Mar; 73(11):1264-1272. PubMed ID: 30846338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review.
    Don-Wauchope AC; Santaguida PL; McKelvie R; Brown JA; Oremus M; Ali U; Bustamam A; Sohel N; Hill SA; Booth RA; Balion C; Raina P
    Heart Fail Rev; 2014 Aug; 19(4):541-51. PubMed ID: 25052419
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.